United Therapeutics Corp.

United Therapeutics Corporation is a United States–based biotechnology company that develops and commercializes therapies for chronic and life-threatening diseases, with a primary focus on pulmonary hypertension, organ transplantation, and regenerative medicine. The company markets pharmaceutical products for pulmonary arterial hypertension and conducts research and development in areas including xenotransplantation, manufactured organs, cell-based therapies, and organ preservation technologies. United Therapeutics serves healthcare providers and patients through commercial operations, clinical development programs, and collaborations with research institutions worldwide. The company operates manufacturing, research, and development facilities supporting its biotechnology and pharmaceutical businesses. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland, United States.